Phosphatidylinositol mannosides: Synthesis and adjuvant properties of phosphatidylinositol di- and tetramannosides

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 22, 2006, Pages 7615-7624

  Ainge, Gary D ^a,c   Parlane, Natalie A ^b   Denis, Michel ^b   Hayman, Colin M ^a   Larsen, David S ^c   Painter, Gavin F ^a  

^a CALLAGHAN INNOVATION   (New Zealand)

^b AGRESEARCH   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Adjuvant; Immunomodulation; Phosphatidylinositol mannosides; Synthesis

Indexed keywords

ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; PHOSPHATIDYLINOSITOL DIMANNOSIDE; PHOSPHATIDYLINOSITOL TETRAMANNOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GLYCOSYLATION; MOUSE; NONHUMAN; TRANSGENIC MOUSE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARBOHYDRATE CONFORMATION; MANNOSIDES; MICE; MICE, INBRED C57BL; OVALBUMIN; PHOSPHATIDYLINOSITOLS;

CORYNEBACTERINEAE; MUS MUSCULUS;

EID: 33749258201     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.07.003     Document Type: Article

References (30)

1. Lussow A.R., Aguado M.T., Del Giudice G., and Lambert P.H. Immunol. Lett 25 (1990) 255
2. Marciani D.J. Drug Discovery Today 8 (2003) 934
3. Shirakawa T., Enomoto T., Shimazu S., and Hopkin J.M. Science 275 (1997) 77
4. Erb K.J., Holloway J.W., Sobeck A., Moll H., and Le Gros G. J. Exp. Med 187 (1998) 561
5. Miescher S.M., and Vogel M. Mol. Aspects Med. 23 (2003) 413
6. Khoo K.H., Dell A., Morris H.R., Brennan P.J., and Chatterjee D. Glycobiology 5 (1995) 117
7. Gilleron M., Ronet C., Mempel M., Monsarrat B., Gachelin G., and Puzo G. J. Biol. Chem. 276 (2001) 34896
8. Ainge G.D., Hudson J., Larsen D.S., Painter G.F., Singh Gill G., and Harper J.L. Bioorg. Med. Chem. 14 (2006) 5632
9. Gilleron M., Quesniaux V.F., and Puzo G. J. Biol. Chem. 278 (2003) 29880
10. Sayers I., Severn W., Scanga C.B., Hudson J., Le Gros G., and Harper J.L. J. Allergy Clin. Immunol 114 (2004) 302
11. Zhang Y., Broser M., Cohen H., Bodkin M., Law K., Reibman J., and Rom W.N. J. Clin. Invest. 95 (1995) 586
12. Morita Y.S., Patterson J.H., Billman-Jacobe H., and McConville M.J. Biochem. J. 378 (2004) 589
13. Severn W.B., Furneaux R.H., Falshaw R., and Atkinson P.H. Carbohydr. Res. 308 (1998) 397
14. Gilleron M., Nigou J., Nicolle D., Quesniaux V., and Puzo G. Chem. Biol. 13 (2006) 39
15. Fischer K., Scotet E., Niemeyer M., Koebernick H., Zerrahn J., Maillet S., Hurwitz R., Kursar M., Bonneville M., Kaufmann S.H., and Schaible U.E. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10685
16. Zajonc, D. M.; Ainge, G. D.; Painter, G. F.; Severn, W. B.; Wilson, I. A. Unpublished results.
17. Stepanov A.E., Shvets V.I., and Evstigneeva R.P. Zh. Obshch. Khim. 47 (1977) 1653
18. Elie C.J.J., Dreef C.E., Verduyn R., Van der Marel G.A., and Van Boom J.H. Tetrahedron 45 (1989) 3477
19. Stadelmaier A., and Schmidt R.R. Carbohydr. Res. 338 (2003) 2557
20. Rademacher, T. W.; Schmidt, R.; Stadelmaier, A.; (Lascaux Pharmaceuticals Limited, UK). Application: WO, 2003; p. 87.
21. Elie C.J.J., Verduyn R., Dreef C.E., Van der Marel G.A., and Van Boom J.H. J. Carbohydr. Chem. 11 (1992) 715
22. Watanabe Y., Yamamoto T., and Okazaki T. Tetrahedron 53 (1997) 903
23. Watanabe Y., Yamamoto T., and Ozaki S. J. Org. Chem. 61 (1996) 14
24. Jayaprakash K.N., Lu J., and Fraser-Reid B. Bioorg. Med. Chem. Lett. 14 (2004) 3815
25. Liu X., Stocker B.L., and Seeberger P.H. J. Am. Chem. Soc. 128 (2006) 3638
26. Podlasek C.A., Wu J., Stripe W.A., Bondo P.B., and Serianni A.R. J. Am. Chem. Soc. 117 (1995) 8635
27. Bock K., Lundt I., and Pedersen C. Tetrahedron Lett. (1973) 1037
28. Wegmann B., and Schmidt R.R. J. Carbohydr. Chem. 6 (1987) 357
29. 2BOTf.
30. Barnden M.J., Allison J., Heath W.R., and Carbone F.R. Immunol. Cell Biol. 76 (1998) 34